Teva Psychiatry

Discussion in 'Teva Neuroscience' started by anonymous, Jun 21, 2017 at 7:09 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    The new name is Teva Psychiatry. What about the CGRP Migraine drug? Are we not going to be promoting that when it comes out?
     

  2. anonymous

    anonymous Guest

    Could the "Paper Tiger" be a bigger clown than on today's conference call. He is the director of our unit and gets on a call from either a boat or inside a ceiling fan and is unable to answer our questions. We are out here calling on targets that don't even treat spasm and this is our "director"??

    The new name must mean Paper Tiger got us thrown out of CGRP.
     
  3. anonymous

    anonymous Guest

    At P club they said we wouldn't get it we're just primary care and psych for TD.
     
  4. anonymous

    anonymous Guest

    Okay. I am off to interview with Amgen then.
     
  5. anonymous

    anonymous Guest

    Amgen is for primary care targets. Good luck with that.
     
  6. anonymous

    anonymous Guest

    You believe that the Neuroscience team won't be calling on Primary Care targets with a migraine drug? Think again.
     
  7. anonymous

    anonymous Guest

    Neuro targets only dumbass. It is literally the name of the division.

    A new team will call on other targets. Just like Amgen reps with their product because Novartis is the Neuro.
     
  8. anonymous

    anonymous Guest

    Teva is hiring a new team to sell the migraine drug for primary care? When will the hiring start?
     
  9. anonymous

    anonymous Guest

    Yes, when will the hiring start for this? I am looking to get back with Teva from the last layoff and this sounds great.
     
  10. anonymous

    anonymous Guest

    This is hilarious...Teva brands is about to spin everything off and some actually believe they will be hiring? Teva is going back to the generic model in 2018 and there will be no TN or any other branded division within Teva.
     
  11. anonymous

    anonymous Guest

    Hey dumbass, if that were true, everyone would of been dropped from other divisions during the Feb. cuts, like you. Go away and focus on finding a job. CGRP alone creates 600+ jobs, ask Amgen and Lilly.
     
  12. anonymous

    anonymous Guest

    We all see the expertise exhibited by the Teva corporate team when it comes to launching a new product. No division is safe at this company. They reward the incompetent decision makers.
     
  13. anonymous

    anonymous Guest

    Many are selling CGRP, just not for Teva
     
  14. anonymous

    anonymous Guest

    How many will exit?